Endo Pharm Reiterated at Hold and 3 Reiterated Ratings to Note

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Wall St. Watchdog reveals information about companies for which stock analysts reiterated their ratings on November 6th.

National Retail Properties (NYSE:NNN): RBC Capital Mkts reiterated its rating of Outperform for this company and changed its price target from $33 to $35.

Rigel Pharms (NASDAQ:RIGL): Oppenheimer reiterated its rating of Outperform for this company and changed its price target from $12 to $15.

Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.

Cypress Sharpridge Investments (NYSE:CYS): FBR Capital reiterated its rating of Mkt Perform for this company and changed its price target from $15 to $14.

Endo Pharm (NASDAQ:ENDP): Cantor Fitzgerald reiterated its rating of Hold for this company and changed its price target from $31 to $28.

Don’t Miss: Did the Roof Just Cave in on Zillow?


More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business